Formycon AG (ETR:FYB)
15.48
+0.20 (1.31%)
Nov 16, 2026, 12:46 PM CET
Formycon AG Revenue
Formycon AG had revenue of 14.24M EUR in the quarter ending September 30, 2026, with 35.55% growth. This brings the company's total for the last twelve months to 64.98M, up 35.16% year-over-year. In the year 2025, Formycon AG had annual revenue of 44.48M, down -36.17%. That makes Formycon AG the 25,748th largest company in the world by revenue and 396th in Germany.
Revenue (ttm)
64.98M
Revenue Growth
+35.16%
P/S Ratio
4.41
Revenue / Employee
312.46K
Employees
196
Market Cap
273.58M
Revenue by Geography
- Rest of The World 19.97M 44.9%
- Switzerland 13.42M 30.2%
- Germany 11.09M 24.9%
Fiscal year ended Dec 31, 2025 See the full Formycon AG breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.48M | -25.20M | -36.17% |
| Dec 31, 2024 | 69.67M | -8.02M | -10.32% |
| Dec 31, 2023 | 77.70M | 35.20M | 82.83% |
| Dec 31, 2022 | 42.50M | 5.88M | 16.07% |
| Dec 31, 2021 | 36.61M | 2.32M | 6.76% |
| Dec 31, 2020 | 34.30M | 1.14M | 3.43% |
| Dec 31, 2019 | 33.16M | -42.96B | -99.92% |
| Dec 31, 2018 | 42.99B | 42.96B | 148,135.43% |
| Dec 31, 2017 | 29.00M | 9.47M | 48.48% |
| Dec 31, 2016 | 19.53M | 2.61M | 15.41% |
| Dec 31, 2015 | 16.92M | 4.34M | 34.49% |
| Dec 31, 2014 | 12.59M | 12.31M | 4,456.93% |
| Dec 31, 2013 | 276.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.77B |
| Siemens Healthineers AG | 23.63B |
| Fresenius SE & Co. KGaA | 23.61B |
| Merck KGaA | 21.44B |
| Medios AG | 2.18B |
| MEDICLIN Aktiengesellschaft | 825.43M |
| Evotec SE | 718.32M |
| M1 Kliniken AG | 257.36M |
Formycon AG News
- 3 days ago - Formycon AG Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Formycon AG Earnings release: Q3 2026 - Filings
- 3 days ago - Formycon AG Slides: Q3 2026 - Filings
- 4 days ago - Formycon Doubles Nine-Month Revenue as FYB4Growth Gains Momentum - Wallstreet:Online
- 4 days ago - EQS-News: Formycon Doubles Nine-Month Revenue and Consistently Advances Implementation of its FYB4Growth Strategy - Wallstreet:Online
- 10 days ago - Formycon Revises EBITDA Guidance After FYB201/FYB202 Non-Cash Impairments - Wallstreet:Online
- 10 days ago - Formycon Holds 2026 Outlook, Revises Adj. EBITDA, Reassesses FYB201/202 - Wallstreet:Online
- 10 days ago - EQS-News: Formycon maintains 2026 guidance for revenue, EBITDA and working capital, revises adjusted EBITDA and reassesses FYB201 and FYB202 - Wallstreet:Online